Search results (316)
« Back to PublicationsEffects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Journal article
Malijan GB. et al, (2026), Am J Kidney Dis, 87, 553 - 563.e1
Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials
Journal article
REITH C. et al, (2026), The Lancet
Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccination Against Hospitalizations and Deaths According to Frailty Score: A Post Hoc Analysis of the DANFLU-1 Randomized Trial.
Journal article
Espersen C. et al, (2026), J Infect Dis, 233, e89 - e98
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial
Journal article
Feldballe Bernholm K. et al, (2026), European Journal of Clinical Microbiology and Infectious Diseases
Characteristics of interventional clinical trials registered in ClinicalTrials.gov, 2018-2023.
Journal article
Sullenger RD. et al, (2026), J Clin Transl Sci, 10
A pragmatic individually randomized trial to evaluate the effectiveness of high-dose vs standard-dose influenza vaccine in older adults: Rationale and design of the DANFLU-2 trial.
Journal article
Johansen ND. et al, (2026), Am Heart J, 291, 186 - 198
High-Dose vs Standard-Dose Influenza Vaccine in Chronic Kidney Disease: The DANFLU-2 Trial Subgroup Analysis.
Journal article
Bartholdy KV. et al, (2025), J Am Coll Cardiol, 86, 2636 - 2647
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
Journal article
Johansen ND. et al, (2025), N Engl J Med, 393, 2291 - 2302
Discordance in Creatinine- and Cystatin C-Based eGFR and Clinical Outcomes: A Meta-Analysis.
Journal article
Estrella MM. et al, (2025), JAMA, 334, 1915 - 1926
A Bayesian re-analysis of the DANFLU-1 trial.
Journal article
Modin D. et al, (2025), Hum Vaccin Immunother, 21
Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccine in Older Adults with Diabetes: The DANFLU-2 Randomized Clinical Trial
Journal article
Nielsen AB. et al, (2025), JAMA Internal Medicine
High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial.
Journal article
Pareek M. et al, (2025), Eur Heart J, 46, 4282 - 4290
Effects Of Empagliflozin On Kidney And Cardiac Magnetic Resonance Imaging Measures In Patients With Chronic Kidney Disease: An EMPA-KIDNEY Mechanistic Substudy
Journal article
ZHU D. et al, (2025), American Journal of Kidney Diseases
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: A Prespecified Secondary Analysis of the DANFLU-2 Randomized Clinical Trial.
Journal article
Johansen ND. et al, (2025), JAMA Cardiol, 10, 1186 - 1194
Effects of high-dose versus standard-dose influenza vaccine among patients with chronic lung disease: A prespecified analysis of the DANFLU-1 trial.
Journal article
Duus LS. et al, (2025), Respir Investig, 63, 1309 - 1315